Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Glycosylation: Mapping Uncharted Territory

21.09.2017

Glycosylation is the most abundant protein modification - over half of the proteins in our cells are ‘decorated’ with glycans. These sugar structures alter protein activities in all organisms – from bacteria to human - influencing fundamental processes, like protein folding and transport, cell migration, cell-cell interactions, and immune responses.

However, whereas massive inroads have been made into genomics, metabolomics, or protein and lipid research, glycosylation remains largely unexplored at the proteome scale. There are limited technologies for profiling the complex glycoproteome.


SugarQb is a platform that enables global insights into protein glycosylation and glycan modifications in biological systems.

Glycoproteins can differ not only by the number and location of glycosites, but also by the composition and structure of each glycan. Glycoproteomics is “one of the key frontiers of life sciences”, says study leader Josef Penninger, MD, IMBA Director.

The SugarQb Approach

To overcome the technical limitations that have stymied the field, Penninger’s group developed mass-spectrometry methods and algorithms that finally enable both the comprehensive identification of complex sugar structures and their mapping to sites within the corresponding proteins. Their novel comparative glycoproteomics platform is published in the current issue of Nature.

Termed SugarQb, for Sugar Quantitative Biology, their approach enables global insights into protein glycosylation and glycan modifications in biological systems. They applied this platform to two exciting proof-of-principle studies – an analysis of embryonic stem cell glycoproteomes, and the identification of glycoproteins required for ricin toxicity.

Glycosylated Stem Cell Factors

Using the novel SugarQb methodology, the authors established a first draft of the glycoproteomes of murine and human embryonic stem cells. Their results nearly doubled the number of all known glycoproteins in the entire literature.

They also uncovered multiple novel glycosylated proteins, including evolutionarily conserved as well as species-specific sugar modifications in murine and human stem cell pluripotency factors. Many of the glycosylated proteins they uncovered localize to the plasma membrane and are implicated in cell-to-cell signaling, cell interactions, as well as embryonic development.

Therapeutic Targets for Ricin

Ricin is a highly poisonous plant toxin and bioweapon. The smuggling of ricin raises concerns that it could be utilized by terrorists and terrorist organizations. Several US politicians - including President Barack Obama - received letters containing trace amounts of the poison. There are currently no antidotes for ricin exposure – so various groups, from pharmaceutical companies to the military, are interested in identifying therapies to treat or prevent ricin toxicity. Penninger’s group had just previously discovered that mutant cells defective for fucosylation, a type of glycosylation that adds fucose sugars, were resistant to ricin. However, the fucosylated targets supporting ricin toxicity were unknown.

Using SugarQb, the first authors Jasmin Taubenschmid, PhD student at IMBA, and proteome-researcher Johannes Stadlmann, could now obtain the glycoproteomes of these ricin-resistant cells: the glycoproteins that were altered in the mutant cells might play a role in their resistance.

Indeed, the team discovered six new players that orchestrate ricin toxicity. Loss of any one of these proteins rendered human cells ricin resistant, just like the cells defective for fucosylation. Their findings suggest that fucosylation of these new players is required for ricin sensitivity and provide many new therapeutic targets for drug discovery.

SugarQb is freely available to all scientists. “We hope that our platform will allow research teams all over the world to map this uncharted territory by identifying the sugar structures and their positions on the corresponding proteins,” says Johannes Stadlmann.

“Glycosylation plays a fundamental role in many diseases, including cancer –SugarQb will allow scientists to uncover new mechanisms in biology and treatment strategies for disease. It could also be used by clinicians to define aberrant glycoproteomic signatures as biomarkers of disease and to track responses to therapy,” adds Josef Penninger, last author and scientific director of IMBA.

Original paper: Stadlmann, Taubenschmid et al. „Comparative glycoproteomics of stem cells identifies new players in ricin toxicity”, Nature doi:10.1038/nature24015

About IMBA
IMBA - Institute of Molecular Biotechnology is one of the leading biomedical research institutes in Europe focusing on cutting-edge functional genomics and stem cell technologies. IMBA is located at the Vienna Biocenter, the vibrant cluster of universities, research institutes and biotech companies in Austria. IMBA is a basic research institute of the Austrian Academy of Sciences, the leading national sponsor of non-university academic research. www.imba.oeaw.ac.at

About the Vienna BioCenter
The Vienna BioCenter (VBC) is a leading life sciences location in Europe, offering an extraordinary combination of research, education and business on a single campus. About 1,700 employees, more than 1,300 students, 86 research groups, 17 biotech companies, and scientists from more than 40 nations create a highly dynamic environment. This research was part of the VBC PhD Programme. www.viennabiocenter.org

Mag. Evelyn Devuyst | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht Pollen taxi for bacteria
18.07.2018 | Technische Universität München

nachricht Biological signalling processes in intelligent materials
18.07.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Pollen taxi for bacteria

18.07.2018 | Life Sciences

Biological signalling processes in intelligent materials

18.07.2018 | Life Sciences

Study suggests buried Internet infrastructure at risk as sea levels rise

18.07.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>